CAD 0.02
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.78 Million CAD | 4.75% |
2022 | 1.7 Million CAD | 1.97% |
2021 | 1.67 Million CAD | 6.98% |
2020 | 1.56 Million CAD | -24.9% |
2019 | 2.08 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q4 | 1.78 Million CAD | 3.18% |
2023 Q3 | 1.73 Million CAD | 3.53% |
2023 Q2 | 1.67 Million CAD | 3.34% |
2023 Q1 | 1.61 Million CAD | -5.11% |
2022 Q1 | 1.29 Million CAD | 0.0% |
2022 Q4 | 1.7 Million CAD | 13.83% |
2022 Q3 | 1.49 Million CAD | 0.0% |
2022 Q2 | - CAD | -100.0% |
2021 Q1 | 1.38 Million CAD | 0.0% |
2021 Q4 | - CAD | -100.0% |
2021 Q3 | 1.46 Million CAD | -10.86% |
2021 Q2 | 1.64 Million CAD | 19.33% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | -205.868% |
CanadaBis Capital Inc. | 5.91 Million CAD | 69.829% |
Decibel Cannabis Company Inc. | 32.34 Million CAD | 94.482% |
Entourage Health Corp. | 5.79 Million CAD | 69.187% |
Lifeist Wellness Inc. | 868.65 Thousand CAD | -105.49% |
Cannara Biotech Inc. | 39.73 Million CAD | 95.508% |
Medicure Inc. | 229 Thousand CAD | -679.476% |
PharmaCielo Ltd. | 2.55 Million CAD | 30.094% |
Rubicon Organics Inc. | - CAD | -Infinity% |
BioSyent Inc. | 1.03 Million CAD | -72.01% |
Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -4362.5% |